Abstract
Objective
To identify the preoperative predictors of extraurothelial recurrence (EUR) after radical nephroureterectomy (RNU) in patients with upper tract urothelial carcinoma (UTUC).
Methods
A single-center series of 238 consecutive patients who were treated with RNU for UTUC was evaluated. Recurrence-free probabilities and cancer-specific survival (CSS) were estimated using the Kaplan–Meier method. Multivariate Cox proportional hazards regression models were used to evaluate the association between various clinicopathological factors and EUR.
Results
The median time to EUR was 17.6 months (range 3–73 months). EUR-free survival rates at 1, 3, 5, and 7 years were 87.8, 75.2, 73.5, and 72.6 %, respectively. In multivariate Cox regression analyses, tumor stage (HR 27.4; 95 % CI 7.83–95.8; p = 0.0001) and lymphovascular invasion (LVI) (HR 1.53; 95 % CI 1.22–3.12; p = 0.01) were independently associated with EUR. In patients with EUR, 5-year CSS estimate was 29.2 %. Tumor stage (HR 14.3; 95 % CI 4.55–45.2; p < 0.001) and EUR (HR 2.7; 95 % CI 1.54–4.73; p = 0.001) were the only independent predictors associated with worse CSS.
Conclusions
EUR significantly affected the prognosis in patients with UTUC managed by RNU. Patient with EUR had a greater probability of having higher tumor stages, higher tumor grades, and positive LVI. Tumor stage and LVI were independently associated with a worse EUR-free survival.
Similar content being viewed by others
References
Jamal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130
Raman JD, Scherr DS (2007) Management of patients with upper urinary tract transitional cell carcinoma. Nat Clin Pract Urol 4:432–443
Margulis V, Youssef RF, Karakiewicz PI, Upper Tract Urothelial Carcinoma Group et al (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184:453–458
Favaretto RL, Shariat SF, Chade DC et al (2010) The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 58:574–580
Leow JJ, Martin-Doyle W, Fay AP et al (2014) A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol 66(3):529–541
Chromecki TF, Cha EK, Fajkovic H et al (2012) The impact of tumor multifocalityon outcomes in patients treated with radical nephroureterectomy. Eur Urol 61:245–253
Fleming ID, Cooper JS, Henson DE et al (1997) Genitourinary site. In: Touhey R (ed) AJCC cancer staging manual, 5th edn. Lippincott-Raven, Philadelphia, pp 231–246
Epstein JI, Amin MB, Reuter VR et al (1998) The World Health Organization/International Society of Urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22:1435–1448
Saito K, Kawakami S, Ohtsuka Y et al (2007) The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100:269–273
Kikuchi E, Margulis V, Karakiewicz PI et al (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27:612–618
Zigeuner R, Shariat SF, Margulis V et al (2010) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57:575–581
Sundar SS, Ganesan TS (2007) Role of lymphangiogenesis in cancer. J Clin Oncol 25:4298–4307
Millikan R, Dinney C, Swanson D et al (2001) Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19:4005–4013
Kunju LP, You L, Zhang Y et al (2008) Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol 180:1928–1932
Ku JH, Byun SS, Jeong H et al (2013) Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: a systematic review and meta-analysis. Eur J Cancer 49(12):2665–2680
Hurel S, Rouprêt M, Ouzzane A et al (2013) Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int 111(8):1199–1207
Novara G, Matsumoto K, Kassouf W et al (2010) Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol 57(6):1064–1071
Milojevic B, Djokic M, Sipetic-Grujicic S et al (2013) Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Urol Oncol 31(8):1615–1620
Yagoda A (1987) Chemotherapy of urothelial tumors. Cancer 60:574–585
Raman JD, Lin YK, Kaag M et al (2014) High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol 32(1):47.e9-14. doi:10.1016/j.urolonc.2013.06.015
Kwak C, Lee SE, Jeong IG et al (2006) Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68:53–57
Bamias A, Deliveliotis CH, Fountzilas G et al (2004) Adjuvant chemo-therapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22(11):2150–2154
Vassilakopoulou M, de la Motte Rouge T, Colin P et al (2011) Outcomes after adjuvant chemotherapy in the treatment of high risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a Large Multicenter Collaborative Study. Cancer 117:5500–5508
Milenkovic-Petronic D, Milojevic B, Djokic M et al (2014) The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma. Int Urol Nephrol 46(3):563–569
Acknowledgments
This work was supported by the Ministry for Science and Technology of the Republic of Serbia, through Contact No. 175042 (2011–2014).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zoran Dzamic and Bogomir Milojevic have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Dzamic, Z., Milojevic, B., Kajmakovic, B. et al. Extraurothelial recurrence after radical nephroureterectomy: preoperative predictors and survival. Int Urol Nephrol 47, 775–779 (2015). https://doi.org/10.1007/s11255-015-0946-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-0946-8